Guannan Wang, PhD: No financial relationships to disclose
Presentation Description / Summary: The rapid expansion of genomic and molecular profiling in veterinary oncology is reshaping how we understand, diagnose, and treat canine cancers. This panel will bring together leading experts in canine cancer omics, Lucas Rodrigues, Will Hendricks, Guannan Wang, and Maciej Parys, to discuss recent large-scale sequencing efforts, key recurrent genomic alterations, and their clinical relevance. To set the stage, panelists will review how genomics has reshaped cancer patient stratification and treatment. The discussion will then highlight the comparative oncology perspective: how insights from human cancer research initially guided our understanding in dogs, and how veterinary-specific clinical evidence is now driving prognostic and therapeutic correlations. Attendees will gain a deeper understanding of how clinico-genomic data can inform diagnosis, prognosis and therapeutic options, and advance precision medicine approaches for canine patients.
Learning Objectives:
Understand the impact of large-scale genomic profiling on canine cancer care: how recurrent genomic alterations inform patient stratification, prognosis, and give new opportunities for treatment.
Recognize the role of comparative oncology in advancing veterinary precision medicine: moving from leveraging human cancer data to establishing veterinary-specific clinical evidence that supports prognostic and therapeutic correlations in dogs.